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Abstract 
 
    Endometriosis is a common mysterious and fascinating gynaecological condition with diverse clinical 
manifestations, highly variable and unpredictable clinical course with decreased quality of life. Clinically, Salvia miltiorrhiza 
Bunge (SMB, Chinese Danshen) has been applied to treat endometriosis and get satisfactory results. The present study was 
aimed to explore the effects of the extracts of SMB (ESMB) on the serum levels of cancer antigen 125 (CA-125) and the 
levels of interleukin (IL)-13, IL-18 and tumor necrosis factor-alpha (TNF-alpha) in the peritoneal fluids of rat endometriosis 
models. Three extraction methods for SMB were compared, which are the sample extracted with conventional method, the 
sample extracted with espresso coffee machine and the commercial condensed powder of natural products. We determined 
tanshinone IIA, salvianolic acid B and danshensu in the ESMB of different extraction methods. Forty female 
Sprague-Dawley (SD) rats were randomly divided into ESMB group, Danazol (positive control) group, model group and the 
sham-operation group (Sham group). After all the treatment ended, the serum levels of CA125 and the levels of IL-13, IL-18 
and TNF-alpha in the peritoneal fluids of rat endometriosis models were measured using enzyme-linked immune-sorbent 
assay (ELISA) as directed by the manufacturer. The extraction efficiency of the ESMB samples extracted with coffee 
machine ranged from 600μm to 710μm was the highest. The serum levels of CA-125 and the levels of IL-18 and TNF-alpha 
in the peritoneal fluids of ESMB group, Danazol group and Sham group were significantly lower than those of the Model 
group (P<0.05). The serum levels of CA-125 and the levels of IL-18 and TNF-alpha in the peritoneal fluids of Danazol group 
and ESMB group were significantly higher than those of Sham group, respectively (P<0.05), and no marked difference 
existed between them (P>0.05). The levels of IL-13 in the peritoneal fluids of ESMB group, Danazol group and Sham group 
were significantly higher than those of the Model group (P<0.05). The levels of IL-13 in the peritoneal fluids of ESMB group 
and Danazol group were significantly lower than those of Sham group (P<0.05), and there was no marked difference between 
ESMB group and Sham group (P>0.05). ESMB shows promises in treating endometriosis by markedly decreasing the serum 
levels of CA-125 and the levels of IL-18 and TNF-alpha in the peritoneal fluids and significantly increasing the levels of 
IL-13 in the peritoneal fluids.   
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Introduction 
 
      Endometriosis is a common mysterious and fascinating gynaecological condition with diverse clinical 
manifestations, highly variable and unpredictable clinical course with decreased quality of life (Okeke et al., 2011). 
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Endometriosis affects approximately 10% of women of reproductive age (Giudice and Kao, 2004; Okeke et al., 2011). It most 
commonly afflict women in the late 20s and 30s and the classic symptom complex include dysmenorrhoea, dyspareunia, 
menorrhagia and infertility (Okeke et al., 2011).  
         Salvia miltiorrhiza Bunge (SMB, Chinese Danshen), is one of the most important Chinese medicinal plants, 
which is ranked as a ‘‘Supergrade’’ medicine in the first official book on Chinese herbal drugs, Shen Nong Materia Medica. 
SMB has been listed in the official Chinese Pharmacopoeia for treatment of menstrual disorder and blood circulation diseases 
and for prevention of inflammation (Kuang et al., 2005). Major compounds involved in its activity are quinoid diterpenes 
called tanshinones (tanshinones I, IIA, IIB, cryptotanshinone) and several phenolic acids (salvianolic, rosmarinic, caffeic, 
protocatechuic and danshensu acids)(Matkowski et al., 2008). Tanshinone IIA, salvianolic acid B, and sodium danshensu in 
SMB are usually used as bioactive markers in biological samples or herbal medicinal preparations (Zhou et al., 2005).  
         About 30% of the patients are asymptomatic and the incidence of infertility amongst women suffering from 
endometriosis ranges from 30%-40% (Okeke et al., 2011). The endometriosis-associated inflammatory response, tissue repair 
and neo-vascularization are dependent on the peritoneal fluids macrophages and their secretary products⁄cytokines 
(Fassbender et al., 2011; Huhtinen et al., 2011; Liu and Lang, 2011; Witz, 2002). These cytokines may play major roles in 
regulating cell proliferation, activation, motility, adhesion, chemotaxis and morphogenesis in the pathogenesis of 
endometriosis (Fassbender et al., 2011; Huhtinen et al., 2011; Liu and Lang, 2011; Witz, 2002). Increased peritoneal fluids 
concentration of cytokines that lead to the migration, proliferation, and activation of macrophages have been reported in 
patients with endometriosis (Sharpe-Timms et al., 1994; Weil et al., 1997). Although surgical and hormonal treatment are 
applied as the common interventions, the unpleasant side effects and high rates of relapse limited the range of these 
interventions (Abbott et al., 2004; Flower et al., 2009). Some medicinal plants were shown to be potential treatment for the 
disease (Flower et al., 2007; Wieser et al., 2007), and clinical trials have shown the eminent curative effects of some Chinese 
medicinal plants on the disease (Flower et al., 2009). Salvianolic acid B and Danshensu, 3-(3,4-dihydroxyphenyl) lactic acid 
are two natural phenolic acids of caffeic acid derivatives isolated from SMB. These two components have been reported to 
have potential protective effects from oxidative injury (Zhao et al., 2008). Tanshinone IIA,  the major lipid-soluble 
pharmacological constituent in SMB, was found to attenuate the myocardial infarction pathological changes and improve 
heart function, and reduce macrophage infiltration, indicating the cardioprotective effects of Tanshinone IIA which might be 
attributed to its capacity for inhibiting inflammatory responses (Ren et al., 2010). Clinically, SMB has been applied to treat 
endometriosis and get satisfactory results. The present study was aimed to explore the effects of extracts of SMB (ESMB) on 
the serum levels of cancer antigen 125 (CA-125) and the levels of interleukin (IL)-13, IL-18 and tumor necrosis factor-alpha 
(TNF-alpha) in the peritoneal fluids of rat endometriosis models. These biomarkers for endometriosis have been found with 
clinical values (May et al., 2010; May et al., 2011). In the present study, danazol was used as the control intervention. 
Danazol produces an environment with high androgen and low estrogen levels, which leads to the atrophy of endometriotic 
implants (Selak et al., 2007).  
 
 
Materials and methods 
Chemicals and Materials  
 
         Tanshinone IIA (T4952) was purchased from Sigma Aldrich, UK. Salvianolic acid B, sodium danshensu were 
purchased from Carbosynth limited, UK. Structures are shown in Figure 1. Crude drug (approximately 0.5-1.0cm) and the 
commercial condensed powder of SMB were purchased from Beijing Tong Ren Tang Limited, China. Water and methanol of 
HPLC grade were purchased from Fisher Scientific UK. The liquid chromatographic system used was a Waters HPLC 
System (Waters, Milford, MA, USA) equipped with a 2996 photodiode-array (PDA) UV detector, Waters 626 Pump and 
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Waters 600 Controller (LCD),Waters 717 plus Autosampler. The chromatographic separation of the three compounds was 
achieved by using a reversed-phase HPLC column (Agilent ZORBAX Rx-C18 2.1 x 150mm, 5μm). 
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Figure 1.  Structures of danshensu, salvia acid B and tanshinone II A in SMB 
 
Initial Preparations of the sample extracted with conventional method 
 
         10g of crude drug of SMB was refluxed by Soxhlet extraction for 60min with 100 ml water. After filtration, the 
extraction procedure was repeated once with 80mL water. All the filtrates were combined and concentrated under reduced 
pressure and freeze dried. The flowchart of the extraction is shown in Figure 2.  
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Figure 2: Flowchart of the conventional extraction method 
 
 
Initial Preparations of the sample extracted with espresso coffee machine  
 
         An initial sample study consisted basically of a sample size study followed by a repeated extraction study. Plant 
materials were ground in a coffee grinder (De’longi, Italy). Studies were performed to compare different extraction times, 
and filtrate volumes for different sizes of Chinese medicine powders, in the same volume spoon. The mixed crude powders 
were shaken by Minor Test Sieve Shaker 230V/50HZ for 10 mins. And the powders past sieves test woven wire mesh brass 
BS 410 diameter (Endecotts, UK) with the aperture of 50µm, 100µm, 125µm, 500µm, 600µm, 710µm, 850µm and 1000µm, 
respectively. Compared with the conventional extraction method, the coffee machine extraction method only needed one 
step. 
         Different size of Chinese medicine powders were extracted by the espresso coffee machine (De’longi) for four 
times. Each time 80ml of filtrate was collected in the same volume beaker at ambient temperature. Then the filtrate was 
concentrated and freeze dried. The flowchart of the extraction is shown Figure 3.  
 
Figure 3:  Flowchart of the coffee machine extraction method 
 
Initial preparations of the commercial condensed powder of natural products 
 
         Hot water was added to the commercial condensed powder of SMB (Beijing Tong Ren Tang Limited, China) to 
make the solution for analysis.  
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Final Sample Preparation 
 
         The solution of natural product extracted with three different methods is freeze dried. The freeze dried powder 
was analyzed with HPLC method. Each freeze dried sample was accurately weighed and dissolved with water and filtered 
through a membrane filter (0.45μm) before HPLC analysis.  
 
HPLC analysis for SMB 
 
         The gradient elution for HPLC analysis consisted of two solvent compositions: 0.1% acetic acid in water (solvent 
A) and methanol (solvent B). Gradient elution was carried out according to the following program: solvent B was increased 
from 5 to 30% in the first 25 min, then increased to 35% till 40min, increased to 75% till 60min and then increased to 85% at 
70 min. The flow rate was 0.25μl/min. The sample injection volume was 10μl. The column and auto-sampler were set at 
ambient temperature. The eluent was monitored by a UV detector at the wavelength of 280 nm for all the studied compounds. 
    
Preparation of standard solutions and the calibration curves for SMB 
 
         A standard stock solution 730.0 μg/ml of salvianolic acid B and 470.0 μg/ml of sodium danshensu were prepared 
separately in 50% methanol. A standard stock solution 280.0μg/ml of tanshinone IIA was prepared separately in methanol. 
Standard working solution of salvianolic acid B, tanshinone IIA, and sodium danshensu were prepared by diluting their 
original stock solutions with 50% methanol for salvianolic acid B and sodium danshensu, and methanol for tanshinone IIA, to 
reach the final concentrations of 73.0, 47.0, and 28.0 μg/ml, respectively. The mixed standard solution was prepared with 
200ml of salvianolic acid B, sodium danshensu, and methanol for tanshinone IIA mixed together with the final content of 
15.0, 16.0, and 9.3 μg/ml of salvianolic acid B, sodium danshensu, and methanol for tanshinone II A respectively. Working 
standard solutions and the quality control sample solutions at high, medium and low concentrations were prepared by diluting 
the standard stock solutions with 50% methanol for sodium danshensu and salvianolic acid B, and methanol for tanshinone 
IIA. These solutions were all kept in brown glass bottles and stored at −20 ˚C. Calibration curves were constructed by 
plotting the peak-area ratio of each analyte standard versus analyte concentration. The studied concentration ranges were 
0.73–73.0μg/ml for salvianolic acid B and 0.48–48.0μg/ml for danshensu and 2.8–28.0μg/ml for tanshinone IIA. 
 
Validation of method 
 
         Validation of the HPLC method was performed by determining the intra-day, inter-day accuracy and precision. 
The quality control samples were analyzed in a set of five on a single assay day to determine intra-day precision and accuracy, 
and analyzed in duplicate on each of three separate days to determine inter-day precision and accuracy. The quality control 
samples at low, medium and high concentrations (salvianolic acid B: 18.3, 36.5, 73 μg/ml; danshensu: 11.8, 23.5, 47.0μg /ml; 
tanshinone IIA: 7.0, 14.0, 28.0μg/ml) were used. The limit of detection was defined as the lowest concentration of the analyst 
resulting in a signal-tonoise ratio of 3:1. 
 
Establishment of the model rats with endometriosis  
 
         Forty female Sprague-Dawley (SD) rats with body weight of 140 ±20 g were purchased from the Laboratory 
Animal Center of Zhejiang University (Hangzhou, China). The animals were kept in a room under a 12h light–12h dark cycle 
and environmentally controlled conditions of 22±2°C. The whole protocol of the study was conducted based on the National 
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Research Council's protocol for the care and use of laboratory animals and was approved by the Institutional Review Board. 
Among the 40 rats, 10 rats were randomly taken as the sham-operation group (Sham group). The other 30 rats were used to 
establish the model rats with endometriosis. The method of operational transplantation was used in the present research to 
establish the model rats with endometriosis. Each rat was injected with 0.2mg of diethylstilbestrol to stimulate estrus. Then 
20% urethane (1.5g/kg) was injected intra-abdominally. The abdominal fur was shaved and the skin disinfected. The 
abdominal cavity was opened and the uterus was separated away from the right ovary by 0.5cm, and 2-cm long section of the 
uterus removed. Then the endometrium was separated and divided into three parts and the uterine branch, left ovary and 
parietal peritoneum were respectively sutured. Finally the abdominal cavity was closed and gentamycin sulfate (0.1ml) was 
injected into each rat for 3 days after finishing the above operation. Four weeks after the model rats were made, the 30 model 
rats were randomly divided into three groups (n=10 in each group). For each rat in the Sham group, after the abdominal fur 
was shaved and the skin disinfected, the abdominal cavity was opened and then closed. The Sham group was used to insure 
aseptic conditions.  
 
Group and administration  
 
         The 40 rats were randomly divided into four groups: ESMB group (the rats were orally administrated the extracts 
of SMB at 150 mg/kg once daily for 56 consecutive days), Danazol group (the rats were orally administrated danazol at 36 
mg/kg once daily for 56 consecutive days), model control group (Model group, the rats were orally administrated saline at 
8ml/kg once daily for 56 consecutive days), and Sham group (the rats were orally administrated saline at 8ml/kg once daily 
for 56 consecutive days). After all the treatment ended, the rats were sacrificed and the samples of peritoneal fluids and serum 
were taken. The peritoneal fluid samples of the rats were centrifuged at 12,000 rpm for 10 min at 4 oC. Then, the supernatants 
were collected, aliquoted, and stored frozen at ℃−80  until used for further evaluation. The serum levels of CA-125 and the 
levels of IL-13, IL-18 and TNF-alpha in the peritoneal fluids were detected using enzyme-linked immune-sorbent assay 
(ELISA) as directed by the manufacturer (RUIQI Bio Co. Ltd, Shanghai, China). Danazol was provided by Lianhua 
Medicine Company (Jiangsu, China). 
 
Statistical analysis 
 
         Data were analyzed using the Statistical Package for Social Sciences (SPSS 19.0 for Windows). All the data were 
found normally distributed using the Kolmogorov-Smirnov (KS) test. The comparisons among different groups were 
performed with one-way analysis of variance (ANOVA) and multiple comparison tests were conducted with Bonferroni 
correction procedure. For all the hypothesis tests, significance level was set at P=0.05 and two-tailed tests were used.  
 
 
Results 
Content determination of salvia Acid B, tanshenone II A and danshensu in SMB 
 
         The calibration equation of salvia acid B, tanshenone II A and danshensu is Y=1553098.34X-80999.50 
(R2=0.9997); Y=20953001.7X-191279.55 (R2=0.9993) and Y=499565.11X+141436.50 (R2=0.9994). Figure 8 shows the 
concentration of salvia Acid B, tanshenone II A and danshensu in ESMB extracted with different methods. Figure 8 presents 
that the concentration order from high to low of danshensu is 600-710µm (extracted by coffee machine)> 500-600µm 
(extracted by coffee machine)> 125-500µm (extracted by coffee machine) > conventional boiling method > condensed 
powder. The concentration order from high to low of salvia acid B is conventional boiling method>600-710µm (extracted by 
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coffee machine) >125-500µm (extracted by coffee machine)>500-600µm (extracted by coffee machine) > condensed 
powder. 
         The concentration order from high to low of tanshentone II A is 600-710µm (extracted by coffee machine) > 
125-500µm (extracted by coffee machine) > 500-600µm (extracted by coffee machine) > conventional boiling method > 
condensed powder. ESMB with the powder size between 600-710μm extracted with espresso coffee machine has higher 
concentration of salvianolic acid B, tanshinone IIA and sodium danshensu. At the same time, the coffee machine extraction 
method requirs less time and less sample mass than the conventional method. The HPLC profile of ESMB with the powder 
size between 600μm -710μm is shown in Figure 4. The HPLC profile of commercial condensed SMB powder is shown in 
Figure 5.  
 
 
Figure 4: HPLC profile of ESMB powders (600µm - 710µm) extracted by coffee machine. 
 
 
Figure 5:  HPLC profile of commercial condenced SMB powders 
 
The serum levels of CA125  
 
         As shown in Figure 6, the serum levels of CA-125 in ESMB group, Danazol group and Sham group were 
significantly lower than those of the Model group (P<0.05). The serum levels of CA-125 in ESMB group and Danazol group 
were significantly higher than those of Sham group (P<0.05). The serum level of CA-125 in ESMB group was significantly 
higher than that of Danazol group (P<0.05). 
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Figure 6: The serum levels of cancer antigen 125 (CA-125) 
Data were shown as mean ± SD. (N=10 in each group). The significant difference was set at a P < 0.05, compared with the 
Model group; b P<0.05, compared with the Sham group; c P<0.05, compared with the Danazol group. 
 
The levels of IL-13, IL-18 and TNF-alpha in the peritoneal fluids 
 
         As shown in Figure 7, the levels of IL-13 in the peritoneal fluids of ESMB group, Danazol group and Sham group 
were significantly higher than those of the Model group (P<0.05). The levels of IL-13 in the peritoneal fluids of ESMB group 
and Danazol group were significantly lower than those of Sham group (P<0.05), and there was no marked difference between 
ESMB group and Danazol group (P>0.05).  
 
Figure 7: The levels of interleukin (IL)-13 in the peritoneal fluids  
Data were shown as mean ± SD. (N=10 in each group). The significant difference was set at a P<0.05, compared with the 
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Model group; b P<0.05, compared with the Sham group; c P<0.05, compared with the Danazol group. 
 
As shown in Figure 8, the levels of IL-18 in the peritoneal fluids of ESMB group, Danazol group and Sham group were 
significantly lower than those of the Model group (P<0.05). The levels of IL-18 in the peritoneal fluids of ESMB group and 
Danazol group were significantly higher than those of Sham group (P<0.05), and there was no marked difference between 
ESMB group and Danazol group (P>0.05).  
 
Figure 8: The levels of IL-18 in the peritoneal fluids 
Data were shown as mean ± SD. (N=10 in each group). The significant difference was set at a P<0.05, compared with the 
Model group; b P<0.05, compared with the Sham group; c P<0.05, compared with the Danazol group. 
 
As shown in Figure 9, the levels of TNF-alpha in the peritoneal fluids of ESMB group, Danazol group and Sham group were 
significantly lower than those of the Model group (P<0.05). The levels of TNF-alpha in the peritoneal fluids of ESMB group 
and Danazol group were significantly higher than those of Sham group (P<0.05), and no marked difference existed between 
ESMB group and Danazol group (P>0.05).  
 
 
Figure 9: The levels of tumor necrosis factor-alpha (TNF-alpha) in peritoneal fluids  
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Data were shown as mean ± SD. (N=10 in each group). The significant difference was set at a P<0.05, compared with the 
Model group; b P<0.05, compared with the Sham group; c P<0.05, compared with the Danazol group. 
 
Discussion 
 
         In the present study, CA125, IL-13, IL-18 and TNF-alpha were chosen to reflect the effects of ESMB on the 
model rats with endometriosis. Serum CA-125 measurement is now a consolidated method for diagnosing endometriosis, and 
the serum CA-125 values were found significantly elevated in patients with ovarian and mixed endometriosis lesions (Patrelli 
et al., 2011). The levels of IL-18 in peritoneal fluids were found markedly higher in women with peritoneal, minimal- to 
mild-stage endometriosis than in controls (Arici et al., 2003). The levels of TNF-alpha in peritoneal fluids was demonstrated 
as a biomarker to discriminate between patients with endometriosis and those without (Bedaiwy et al., 2002). We found that 
ESMB markedly decreased the serum levels of CA-125 and the levels of IL-18 and TNF-alpha in the peritoneal fluids and 
significantly increased the levels of IL-13 in the peritoneal fluids.   
         Tanshinone IIA, a major component extracted from SMB can improve blood circulation and treats chronic 
hepatitis and hepatic fibrosis. Tanshinone IIA was found to induce apoptosis as demonstrated by DNA fragmentation, 
poly(ADP-ribose) polymerase and caspase-3 cleavage, increase Bax/Bcl-2 protein ratio, and depolarizate of mitochondrial 
membranes to facilitate cytochrome c release into the cytosol (Che et al., 2010). Tanshinone IIA can reduce the increase of 
caspase-3 activity induced by the amyloid beta-peptide (Abeta), which strongly suggested that tanshinone IIA may be 
effective in treating Alzheimer disease associated with oxidative stress(Liu et al., 2010). A recent study showed that 
tanshinone IIA strongly inhibited the growth of cervical cancer cells through interfering in the process of microtubule 
assembly, which led to G(2)/M phase arrest and sequent apoptosis (Pan et al., 2010). SMB and tanshinone IIA can be used to 
induce Schwann cell proliferation, and in vivo results potentially suggested that SMB and tanshinone IIA might enhance 
neuron regeneration (Shen et al., 2011). Signal transducer and activator of transcription 3 (STAT3) is usually constitutively 
activated in a variety of malignancies, and STAT3 may be a promising target for treatment of tumor cells. Tanshinone IIA 
may serve as an effective adjunctive reagent in the treatment of glioma for its targeting of constitutive STAT3 signaling (Tang 
et al., 2010). Tanshinone IIA were also found to induce apoptosis involving mitochondria intrinsic caspase activation cascade 
and an inhibition of the phosphoinositide 3-kinase /AKT survival pathway (Won et al., 2010). In a study designated to 
evaluate the possible neuroprotective effects of tanshinone IIA on hydrogen peroxide-induced oxidative stress in rats, the 
researchers demonstrated that tanshinone IIA might serve as a novel promising therapeutic agent for oxidative stress injury in 
neurodegenerative diseases (Wang et al., 2011). Tanshinone IIA has multiple effects in the inhibition of the migration of 
human aortic smooth muscle cell and may offer a therapeutic approach to block the process (Jin et al., 2008). It has limited 
brain penetration through the blood-brain barrier owing to the contribution of PgP and multidrug-resistance-associated 
protein (Mrp1/2) (Chen et al., 2007). 
         A liquid chromatography/tandem mass spectrometry (LC/MS/MS) method was developed and validated for the 
determination and pharmacokinetics of danshensu in rat plasma samples using ferulic acid as internal standard (IS) and the 
validated LC/MS/MS method was applied to a pharmacokinetic study in which the extracts of SMB (ESMB, containing 40 
mg/g danshensu) was administered orally to rats at a single dose of 200 mg/kg in 2% water (Li et al., 2008). A dynamic 
continuous ultrasound-assisted extraction with high intensity ultrasonic probe (CUAE-HIUP) combined with solid-phase 
extraction (SPE) for preconcentration and clean-up of the extract prior to high-performance liquid chromatography (HPLC) 
determination of the main biological active ingredients, sodium Danshensu and four tanshinones (dihydrotanshione I, 
tanshinone I, cryptotanshinone and tanshinone IIA) from root of SMB has also been developed in a recent study. and the 
method was successfully applied to the determination of the five biological active ingredients in root of SMB and 
SMB-containing pharmaceutical formulations (Yang et al., 2007).  
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         In the present study, three extraction methods for SMB were compared, which are the samples extracted with 
conventional method, the sample extracted with espresso coffee machine and the commercial condensed powder of natural 
products. The extraction efficiency of the ESMB samples range from 600μm to 710μm is the highest. We determined 
tanshinone IIA, salvianolic acid B and danshensu in the ESMB of different extraction methods. Further studies are needed to 
be conducted on the other potential mechanisms involved in ESMB relieving endometriosis.  
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